CANCER HUNT INITIATIVE

Overview & Introduction

Precision oncology support for veterans — designed to augment care, not disrupt it.


INTRODUCTION

SOTERIA Precision Medicine Foundation is reaching out to explore a potential partnership in service of a population we believe deserves greater access to precision oncology: our nation's veterans.

SOTERIA is a 501(c)(3) nonprofit whose Cancer Hunt Initiative was built around a straightforward but urgent premise: veterans facing cancer diagnoses should have access to comprehensive genomic profiling and biomarker analysis, regardless of insurance, at no cost to the patient and at no additional administrative burden their care team, treating oncologist, or medical institution.

We are actively seeking to partner with clinicians, researchers, and institutions serving veteran and military populations in order to expand access to robust genomic testing, support treating teams with actionable data, and contribute to a growing body of exposure-related oncology research.

SOTERIA is not asking institutions to change how they practice medicine. We are asking for a partnership in access — a way to ensure that military and veteran patients within your care have a path to precision oncology support that runs alongside their existing treatment, at no cost to them and no burden to your team.

A partnership with SOTERIA is a low-friction, high-impact arrangement. It begins with a conversation and a willingness to identify patients who may benefit. Everything else — intake, records, sequencing, navigation, and findings delivery — is managed by SOTERIA.

Our goal is to inform and support the care you are already providing.

Returning meaningful molecular insights to you and your patient, opening doors to relevant clinical trials, and ensuring no veteran falls through the cracks simply due to lack of access.

THE NEED — WHY THIS INITIATIVE EXISTS

~1 in 7

Active-duty deaths known caused by cancer 2010–2020

Age 28

Average age of service members studied

+40%

More cancer deaths than combat deaths in the final decade of war

From Vietnam and Agent Orange to Gulf War Illness to the 9/11 responder crisis, the pattern is consistent: toxic exposures, delayed recognition, and preventable deaths. The Post-9/11 generation is following the same trajectory. SOTERIA exists to interrupt that pattern.

PARTNERSHIP AT A GLANCE

What we ask of you

✔  Identify veteran patients with active cancer diagnoses who may benefit from precision oncology support

Any referral pathway — VA-connected, community oncology, subspecialist, or direct

✔  Make a warm introduction to SOTERIA

A brief conversation with your patient, or a forwarded referral form — that's it

✔  Share relevant medical records with patient consent

SOTERIA coordinates consolidation; your team is not burdened with logistics

✔  Optionally participate in Molecular Tumor Board review

Select cases only — treating physicians are invited, never required

What your institution receives

✔  Molecular findings returned directly to your team

CLIA-certified reports and plain-language summaries for each enrolled patient

✔  No administrative burden

SOTERIA manages intake, records, sequencing, navigation, and follow-up

✔  Contribution to a first-of-kind research dataset

Military and veteran cancer genomics — exposure-linked patterns, mutational signatures, outcomes data

✔  Access to MTB expertise via TGen / City of Hope

For complex cases, a multidisciplinary review at no cost to the institution or patient

✔  Positioning as a precision oncology access point

For the veteran community in your region — at no cost and no clinical disruption

SOTERIA is not a competing care provider.

We do not provide clinical care, seek to move patients away from their treating team, or disrupt existing workflows. SOTERIA supports the veteran and the treating clinicians by consolidating records, funding or facilitating sequencing, identifying precision oncology gaps, researching clinical trial options, and helping the patient prepare for informed conversations with their oncologist.

WHAT SOTERIA PROVIDES

  • Dedicated nurse navigation for test requisition support, logistics management, and patient education

  • Medical records consolidation and case summary preparation

  • Somatic Sequencing — Whole Exome, Transcriptome, and Whole Genome Sequencing Research-Use Only (WGS-RUO with TGen / City of Hope)

  • Germline Sequencing — multi-cancer panel specifically designed detect heritable germline mutations

  • Molecular interpretation, pathway analysis, and CureMatch predictive analytics (when applicable)

  • Clinical trial identification and informed treatment pathway support

  • Multidisciplinary RUO Molecular Tumor Board review for complex cases

  • Longitudinal follow-up and population molecular analysis

WHAT SOTERIA DOES NOT DO

  • Replace oncology care or direct treatment decisions

  • Transfer patients away from their treating team

  • Disrupt existing clinical workflows

  • Require referrals through the VA — any pathway qualifies

Supported by a multidisciplinary team of nurse navigators, PhD-level biomarker scientists, oncology physicians, and logistics coordinators — SOTERIA manages the logistics from medical record collection, test requisitioning, to patient education to reduce the burden on clinical teams.

HOW TO ENGAGE

1

Start with a conversation

No commitment required. Schedule a 20-minute call with Rob Newson or Amanda Skeen to discuss your patient population, referral volume, and whether this is a meaningful fit for your institution.

2

Identify a pilot cohort

Work with SOTERIA to identify a small group of veteran patients who may benefit. SOTERIA can help you assess eligibility without creating administrative burden for your team.

3

Submit referrals via the clinician form

Once ready, referring is as simple as completing a one-page form. SOTERIA handles everything from intake through findings delivery.

4

Receive findings and stay involved

Molecular reports are returned to your team. For select cases, your clinicians are invited to participate in Molecular Tumor Board review with TGen / City of Hope.

CLINICAL & REFERRAL INQUIRIES

Amanda Skeen

Co-Founder & COO

amanda@soteriapmf.org

VETERAN COMMUNITY OUTREACH

Rob Newson

Chief Community Officer | Retired SEAL

619-203-3524 | rob@soteriapmf.org

You Don’t Have To Navigate This Journey Alone

Schedule a Consult

If you are navigating a cancer diagnosis, don’t fight alone.

Our dedicated team is ready to help you access the personalized, genomic-led care you deserve. Take the first step today by scheduling with one of our navigators.

Donate to the Mission

Every dollar makes a difference for our Special Operations Community.

Your gift provides immediate and lifesaving access to genomic testing and expert navigation.